Bangkok Lab and Cosmetic PCL

Capital Structure and Liquidity Bangkok Lab and Cosmetic maintains a relatively strong liquidity position with a current ratio of 2.01, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's free cash flow is negative at -559,933,080 THB, primarily due to a capital expenditure of -682,872,080 THB, which suggests significant investment in long-term assets. The company's cash and equivalents amount to 123,837,480 THB, but this is offset by long-term debt of 223,301,040 THB, resulting in a net cash position that is negative. ### Profitability and Returns The company's profitability is reflected in its return on equity (ROE) of 10.43% and return on assets (ROA) of 7.31%, both of which are above the industry median for pharmaceutical companies. The gross profit margin is 30.0%, and the operating margin is 13.7%, indicating efficient cost management and strong operational performance. ### Segments and Geographic Exposure Bangkok Lab and Cosmetic operates through a single segment focused on pharmaceuticals and medicinal chemical products. The company's revenue is concentrated in Thailand, with no significant international operations disclosed in the financial data. This concentration may expose the company to local economic and regulatory risks. ### Growth Trajectory The company's revenue for the latest period is 1,667,492,920 THB, but there is no specific growth trajectory provided in the outlook. The capital expenditure suggests a focus on long-term growth through asset investment, but the negative free cash flow indicates that this growth is currently funded through operational cash flow and debt. ### Risk Factors The company faces medium liquidity risk due to its negative free cash flow and significant capital expenditures. The dilution risk is low, as there is no indication of share issuance or dilution in the near term. The company's debt-to-equity ratio of 0.13 suggests a conservative capital structure, but the negative net cash position after subtracting total debt is a key flag. ### Recent Events There are no specific recent events or filings mentioned in the provided data. The company's ESG controversies score is 100.0, indicating no major controversies, while its governance and social pillar scores are 38.1 and 58.9, respectively.